|
|
|
|
|
|
|
|
|
|
Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis
Conclusion Cisplatin is associated with a significant increase in the risk of VTEs in patients with advanced solid tumors when compared with non–cisplatin-based chemotherapy.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.